PRF Technologies (PRFX) Total Current Liabilities (2019 - 2025)

PRF Technologies (PRFX) posted quarterly Total Current Liabilities of $2.4 million for Q4 2025, little changed year-on-year from $2.4 million in Q4 2024, and down 0.61% on a QoQ basis from $2.5 million in Q2 2025.

PRF Technologies (PRFX) Total Current Liabilities (2019 - 2025) Analysis & Trends

PRF Technologies (PRFX) has reported Total Current Liabilities for 7 consecutive years, with $2.4 million the latest figure, recorded in Q4 2025.

  • Quarterly Total Current Liabilities changed 0.04% year-over-year to $2.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.4 million (changed 0.04% YoY) and the FY2025 annual result came in at $2.4 million, changed 0.04% from the prior year.
  • Total Current Liabilities declined to $2.4 million in Q4 2025 per PRFX's latest filing, from $2.5 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for PRFX reached as high as $4.9 million in Q2 2024 and fell as low as $549000.0 in Q2 2022.
  • A 5-year average of $1.5 million and a median of $1.1 million in 2023 frame the typical range for Total Current Liabilities.
  • Annual changes were most pronounced in 2021 — Total Current Liabilities plunged 91.08% — and 2024, when it soared 346.26%.
  • Year by year, Total Current Liabilities stood at $757000.0 in 2021, then surged by 40.55% to $1.1 million in 2022, then sank by 37.5% to $665000.0 in 2023, then surged by 267.22% to $2.4 million in 2024, then retreated by 0.04% to $2.4 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $2.4 million, $2.5 million, and $2.4 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 6.56 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.53 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 2.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 18.06 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 13.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 6.81 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 831.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 1.66 Bn
10 PRF Technologies 745,168.93 451,168.93 - 2.44 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.44 Mn
Jun 30, 2025 2.46 Mn
Dec 31, 2024 2.44 Mn
Jun 30, 2024 4.89 Mn
Mar 31, 2024 3.25 Mn
Dec 31, 2023 665,000.00
Sep 30, 2023 1.10 Mn
Jun 30, 2023 1.10 Mn
Mar 31, 2023 1.28 Mn
Dec 31, 2022 1.06 Mn
Sep 30, 2022 1.19 Mn
Jun 30, 2022 549,000.00
Mar 31, 2022 768,000.00
Dec 31, 2021 757,000.00
Sep 30, 2021 628,000.00
Jun 30, 2021 613,000.00
Mar 31, 2021 741,000.00
Dec 31, 2020 961,000.00
Jun 30, 2020 6.87 Mn
Dec 31, 2019 6.34 Mn